AQLGX
Price
$17.85
Change
+$0.15 (+0.85%)
Updated
Nov 19 closing price
Net Assets
51.04M
GFACX
Price
$73.35
Change
+$0.38 (+0.52%)
Updated
Nov 19 closing price
Net Assets
327.37B
Interact to see
Advertisement

AQLGX vs GFACX

Header iconAQLGX vs GFACX Comparison
Open Charts AQLGX vs GFACXBanner chart's image
Alta Quality Growth Institutional
Price$17.85
Change+$0.15 (+0.85%)
VolumeN/A
Net Assets51.04M
American Funds Growth Fund of Amer C
Price$73.35
Change+$0.38 (+0.52%)
VolumeN/A
Net Assets327.37B
AQLGX vs GFACX Comparison Chart in %
View a ticker or compare two or three
VS
AQLGX vs. GFACX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AQLGX is a Hold and GFACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 327B vs. AQLGX (51M). AQLGX pays higher dividends than GFACX: AQLGX (0.02) vs GFACX (0.00). AQLGX was incepted earlier than GFACX: AQLGX (7 years) vs GFACX (25 years). GFACX (1.36) is less costly to investors than AQLGX (1.15). AQLGX is a more actively managed with annual turnover of: 27.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than AQLGX: GFACX (250) vs AQLGX (2500). GFACX annual gain was more profitable for investors over the last year : 4.83 vs. AQLGX (-3.31). GFACX return over 5 years is better than : 25.13 vs. AQLGX (19.43).
AQLGXGFACXAQLGX / GFACX
Total Expense Ratio0.791.3658%
Annual Report Gross Expense Ratio1.151.3685%
Fund Existence7 years25 years-
Gain YTD5.92515.04139%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets51M327B0%
Annual Yield % from dividends0.020.00-
Returns for 1 year-3.314.83-69%
Returns for 3 years30.4655.6755%
Returns for 5 years19.4325.1377%
Returns for 10 yearsN/A70.54-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CDE14.700.32
+2.23%
Coeur Mining
MBAV10.58N/A
N/A
M3 Brigade Acquisition V Corp.
JANX28.84-0.18
-0.62%
Janux Therapeutics
TLPH1.32-0.02
-1.49%
Talphera
FBIOP6.76-0.14
-2.08%
Fortress Biotech